Investment Rating - The report maintains an "Outperform" rating for China XLX Fertiliser with a target price of HK$5.18, based on a current price of HK$3.99 [1][8]. Core Insights - In 2024, the net profit attributable to the parent company increased by 22.96% year-on-year, driven by significant investment income from the sale of a subsidiary [5][6]. - The company achieved a revenue of 23.129 billion yuan in 2024, a slight decrease of 1.48% year-on-year, with a gross profit of 3.931 billion yuan, down 6.12% [5][6]. - The board proposed a dividend policy for 2025-2027 with a distribution ratio of at least 25% of audited net profit attributable to shareholders, and a minimum dividend of 0.24 yuan per share [5][6]. Revenue Breakdown - The fertilizer segment accounted for 58% of total revenue, while the chemical segment contributed 37% in 2024 [6][7]. - Urea revenue increased by 6.3% year-on-year to 7.306 billion yuan, with a sales volume growth of 29% [6][7]. - Compound fertilizers saw a revenue decrease of 2% to 5.994 billion yuan, with a slight sales volume decline of 0.3% [6][7]. - Methanol revenue grew by 14.5% year-on-year to 2.678 billion yuan, with a sales volume increase of 16% [6][7]. Ongoing Projects - The company is progressing with ongoing projects, including a 60,000-tonne polyformaldehyde project and a 300,000-tonne compound fertilizer project, both expected to enhance market presence [7][8]. - Future projects include a 920,000-tonne compound fertilizer and 160,000-tonne melamine facility, expected to start production in early 2027 [7][8]. Earnings Forecast - The earnings forecast for 2025-2027 shows a projected net profit of 1.153 billion yuan in 2025, down 29.95%, followed by 1.611 billion yuan in 2026 and 2.142 billion yuan in 2027 [8][6]. - The target price is set at HK$5.18, based on a PE ratio of 5.3 times for 2025 [8].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 6.5, indicating a potential upside of 54% from the current price of HKD 4.2 [6][4]. Core Insights - The company achieved a revenue of RMB 23.13 billion in 2024, a slight decrease of 1% year-on-year, while the net profit attributable to shareholders increased by 23% to RMB 1.46 billion [2][4]. - The company has announced a dividend policy for 2025-2027, committing to a distribution rate of no less than 25% of audited net profit and a minimum dividend of RMB 0.24 per share [2][4]. - The report anticipates net profits for 2025-2027 to reach RMB 1.1 billion, RMB 1.88 billion, and RMB 2.82 billion, reflecting year-on-year changes of -25%, +71%, and +50% respectively [4][6]. Revenue and Profit Analysis - Urea revenue was RMB 7.31 billion, up 6% year-on-year, but prices fell by 17% due to increased industry capacity and export restrictions, leading to a 4 percentage point decline in gross margin to 25% [3]. - Compound fertilizer revenue decreased by 2% to RMB 6 billion, with a gross margin increase of 2.1 percentage points to 15% [3]. - Methanol revenue rose by 15% to RMB 2.68 billion, with a gross margin increase of 9.2 percentage points to 8.6% [3]. - The company is facing an oversupply issue in the urea market, with an expected addition of 6.6 million tons of capacity in 2025 [3]. Capacity Expansion - The company is expanding its production capacity, with several projects coming online, including a 60,000-ton formaldehyde project and a 300,000-ton compound fertilizer project [4]. - By the end of 2027, the company's fertilizer production capacity is expected to exceed 13 million tons, making it the largest fertilizer producer in China [4].

Core Viewpoint - China Heart and Heart Fertilizer (01866.HK) reported a slight revenue decline of approximately 1% for the fiscal year 2024, but achieved a significant net profit growth of 23%, indicating resilience in its business model despite market challenges [1][3]. Financial Performance - The company recorded total revenue of 23.128 billion yuan for 2024, a year-on-year decrease of about 1% [1]. - The net profit attributable to shareholders was 1.459 billion yuan, reflecting a 23% increase compared to the previous year [1]. - The proposed final dividend is 0.26 yuan per share [1]. Sales and Product Performance - Urea sales revenue reached 7.306 billion yuan, up 6.3%, driven by a 29% increase in urea sales volume, although prices fell by 17% due to market supply-demand imbalances [3]. - Compound fertilizer sales revenue was 5.994 billion yuan, down 2%, with a slight volume decrease of 0.3% attributed to increased market supply [3]. - Methanol sales revenue increased by 14.5% to 2.678 billion yuan, supported by a 16% rise in sales volume and a 10.6% reduction in production costs [3]. - DMF sales volume surged by 36%, marking it as the fastest-growing product category for the company [3]. Strategic Focus and Cost Management - The company is focusing on high-value chemical products, evidenced by the disposal of its coal mine subsidiary and investments in new projects [4]. - The average production cost of methanol decreased by 10.6%, while compound fertilizer production costs fell by 4%, showcasing the company's cost management capabilities [4]. - The proportion of high-efficiency fertilizers, such as liquid and water-soluble fertilizers, increased to 35% [4]. Future Outlook - For 2025, the company anticipates a stable nitrogen fertilizer supply-demand balance, with potential price stabilization for urea due to seasonal agricultural demand [5]. - The company plans to continue expanding high-quality production capacity and aims to exceed a total output of 10 million tons [5]. - Analysts believe that the company's integrated supply chain advantages and differentiated capabilities position it well for a potential recovery in the industry [5].

第 1 頁 共 2 頁 v 1.1.1 EF001 EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | 股票發行人現金股息公告 | | | 發行人名稱 | 中國心連心化肥有限公司 | | 股份代號 | 01866 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2024年12月31日止之末期股息 | | 公告日期 | 2025年3月28日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2024年12月31日 | | 宣派股息的報告期末 | 2024年12月31日 | | 宣派股息 | 每 股 0.26 RMB | | 股東批准日期 | 有待公佈 | | 香港過戶登記處相關信息 | | | 派息金額及公司預設派發貨幣 | HKD， 金額有 ...

Financial Performance - The total revenue for the fiscal year ending December 31, 2024, was RMB 23,128,292, a decrease of 1.5% compared to RMB 23,475,338 in the previous fiscal year[3] - Gross profit for the same period was RMB 3,931,083, down 6.1% from RMB 4,187,020 in the previous year[3] - Net profit for the year was RMB 2,013,620, representing an increase of 23% from RMB 1,637,294 in the previous year[3] - Basic earnings per share increased to RMB 120.05, up from RMB 96.95, reflecting a growth of 23.8%[3] - The company reported an increase in other income and gains to RMB 1,061,152, significantly up from RMB 298,931 in the previous year[3] - The company reported a pre-tax profit of RMB 2,376,436,000 and a net profit of RMB 2,013,620,000 for the year[15] - The company’s net profit attributable to shareholders increased by 23% year-on-year to RMB 1,459,000,000 in 2024, driven by significant investment income from the sale of its subsidiary[36] - Net profit rose by approximately RMB 377 million or about 23% from RMB 1,637 million in FY2023 to RMB 2,014 million in FY2024[52] Assets and Liabilities - Non-current assets totaled RMB 26,217,520, an increase of 11.3% from RMB 23,550,108 in the previous year[4] - Total assets reached RMB 32,518,244, up 11.5% from RMB 29,133,496 in the previous year[4] - Total liabilities increased to RMB 19,996,456, a rise of 7.4% from RMB 18,622,498 in the previous year[6] - The company’s bank loans and other borrowings totaled RMB 12,855,312,000 in 2024, compared to RMB 11,633,132,000 in 2023[33] - Approximately 40.97% of the group's debt, amounting to RMB 5,267 million, is due within one year as of December 31, 2024[63] - The debt-to-equity ratio improved from 70.59% in FY2023 to 69.66% in FY2024, with a net debt of RMB 18,042 million[54] Revenue Breakdown - Total revenue for the year ended December 31, 2024, was RMB 23,128,292,000, with external customer sales contributing RMB 23,128,292,000[15] - The segment profit for the automotive urea division was RMB 1,803,927,000, while the pharmaceutical segment contributed RMB 895,955,000[15] - The sales revenue from finished urea increased by approximately RMB 432,000,000 or 6.3% to about RMB 7,306,000,000 in 2024, supported by a 29% increase in sales volume[37] - The sales revenue of compound fertilizer was approximately RMB 5,994,000,000, a decrease of about RMB 136,000,000 or 2% compared to the fiscal year 2023[38] - Methanol sales revenue rose by approximately RMB 339,000,000 or 14.5% to about RMB 2,678,000,000 in fiscal year 2024, with a 16% increase in sales volume attributed to recovering domestic manufacturing demand[40] - The sales revenue of automotive urea solution decreased by approximately RMB 57,000,000 or 13% to about RMB 377,000,000 in fiscal year 2024, with a 10.3% decline in average selling price[41] - The sales revenue of melamine decreased by approximately RMB 44,000,000 or 5.6% to about RMB 740,000,000 in fiscal year 2024, with a 11.3% decline in average selling price[42] - DMF sales revenue increased by approximately RMB 145,000,000 or 14% to about RMB 1,192,000,000 in fiscal year 2024, driven by a 36% increase in sales volume[43] Expenses and Costs - The cost of goods sold for inventory was RMB 19,197,209 in 2024, slightly down from RMB 19,288,318 in 2023[18] - Depreciation of property, plant, and equipment increased to RMB 1,605,043 in 2024 from RMB 1,492,772 in 2023, reflecting higher capital expenditures[18] - Selling and distribution expenses increased by approximately RMB 90,000,000 or 15% to about RMB 708,000,000 in fiscal year 2024, driven by incentives for sales personnel and increased marketing activities[48] - Financial costs decreased by approximately RMB 85 million or about 15% from RMB 580 million in FY2023 to RMB 495 million in FY2024, primarily due to refinancing high-cost loans and strategic bank partnerships[50] - Income tax expenses increased by approximately RMB 61 million or about 20% from RMB 302 million in FY2023 to RMB 363 million in FY2024[51] Future Plans and Strategies - The company plans to continue expanding its product offerings, focusing on differentiated products such as urea and methanol[8] - The company expects to implement the new accounting standards starting from January 1, 2027, with early application permitted[13] - The group aims to expand production capacity, targeting a total output exceeding 10 million tons, while introducing advanced industry technologies[57] - The group is focusing on differentiated products and enhancing R&D efforts to meet increasing market demand for high-efficiency fertilizers[56] Shareholder Returns - The company plans to distribute a final dividend of RMB 0.26 per share for the year ending December 31, 2024, up from RMB 0.24 in 2023[21] - The company proposed a dividend policy for the years 2025 to 2027, with a payout ratio of no less than 25% of audited net profit attributable to shareholders and a minimum dividend of RMB 0.24 per share[24] - The company repurchased a total of 6,312,000 shares at a total cost of HKD 24,609,000, representing approximately 0.5% of the issued shares as of December 31, 2024[71] Employee and Operational Metrics - The group employed 11,787 employees as of December 31, 2024, an increase from 10,390 employees in 2023, indicating growth in workforce[74]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 劉興旭 香港，二零二五年三月十四日 於本公告日期，本公司執行董事為劉興旭先生、張慶金先生及閆蘊華女士；本公司獨立 非執行董事為王建源先生、李生校先生、王為仁先生及李紅星先生。 中國心連心化肥有限公司（「本公司」）之董事會（「董事會」）謹此宣佈，本公司將於2025年3 月28日（星期五）舉行董事會會議，其中議程包括考慮及批准刊發本公司及其附屬公司截 至2024年12月31日止年度之綜合全年業績公告於香港聯合交易所有限公司網站，以及考 慮派發末期股息之建議（如有）。 承董事會命 中國心連心化肥有限公司 董事會主席 CHINA XLX FERTILISER LTD. * 1866 董事會會議召開日期 * 僅供識別 ...

廣西基地一期復合肥項目成功投產 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 CHINA XLX FERTILISER LTD. * 1866 自願公告 於本公告日期，本公司執行董事為劉興旭先生、張慶金先生及閆蘊華女士；及本公司獨 立非執行董事為王建源先生、李生校先生、王為仁先生及李紅星先生。 * 僅供識別 - 2 - 中國心連心化肥有限公司（「本公司」）董事會（「董事會」）欣然宣佈，二零二四年十二月二 十六日，本公司附屬公司廣西心連心化學工業有限公司（「廣西基地」）一期復合肥項目順 利投入生產，設計產能30萬噸╱年。 廣西基地共規劃三期復合肥項目，總產能為100萬噸╱年。經市場調研，隨著農業產業的 發展，華南地區對肥料的需求持續增長。廣西基地所生產的高效復合肥產品，有助於減 少化肥施用總量，促進土壤健康和生態平衡，助力實現農業綠色可持續發展。 廣西基地位於廣西壯族自治區貴港市桂平新材料產業園內，交通條件便利，具有重要的 區域經濟輻射作用，能夠便捷 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 CHINA XLX FERTILISER LTD. * 1866 自願公告 關於6萬噸聚甲醛項目之最新進展 本公告乃自願作出，旨在使中國心連心化肥有限公司（「本公司」，連同其附屬公司統稱為 「本集團」）股東及潛在投資者知悉本公司之最新業務發展。 誠如該公告所披露，該項目是公司高質、高效發展戰略的部署之一，該項目的順利建 成、運行，不僅有利於新疆基地資源利用效率提高，還實現了基礎化工甲醇的產業鏈延 伸升級，符合本集團新疆基地「資源高轉化」的發展定位，有助於本集團收入及利潤的提 升。此外，該項目亦標誌著本集團將更好的發揮研發優勢，形成技術核心競爭力，更好 滿足國內外高端化工新材料領域的消費升級需要。基於上述，董事會認為該項目有利於 本集團的長遠發展，利於提升本集團的整體利益，更好實現高質量發展的社會價值。 - 1 - 本公司股東及潛在投資者於買賣本公司股份時，務請審慎行事。 承董事會命 中國心連心化肥有限公 ...

| 公司名稱： | China XLX Fertiliser Ltd. 中國心連心化肥有限公司（於新加坡註冊成立之有限公司） | | | | --- | --- | --- | --- | | 表格類別： 呈交日期： | 股票 2024年12月3日 | 狀態： | 新提交 | 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 01866 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不會就本公告全部或任何部分內容而 產生或因倚賴該等內容而引致的任何損失承擔任何責任。 CHINA XLX FERTILISER LTD. * 1866 2024年11月29日舉行之股東特別大會之投票結果 董事會欣然宣佈，於2024年11月29日舉行之股東特別大會上提呈之全部決議案已獲正 式通過。 中國心連心化肥有限公司（「本公司」）董事會（「董事會」）欣然宣佈，於2024年11月29日舉 行之本公司股東特別大會（「股東特別大會」）上提呈之決議案已以一股一票投票表決方式 獲正式通過。 投票結果如下： | | 普通決議案 | 票數(%) | （附註(a)） | | --- | --- | --- | --- | | | | 贊成 | 反對 | | 1. | 考慮及批准本公司日期為2024年11月6日的 | 356,920,316 | 0 | | | 通函所載第8項決議案的建議修訂，內容有 | (100.00%) | (0.00%) | | | 關於2024年5月17日舉行的本公司股東週年 | ...